Robert E. Mcnamara

This profile gathers the share dealings of Robert E. Mcnamara across 2 companies, led by Axonics, Inc. and Northstar Neuroscience, Inc. Over a trading history stretching from 19 June 2009 to 13 January 2021, the count stands at 7 filings.

No open-market purchase appears, only 1 sale worth €389k. Outside the open market, there are 4 share grants and 2 option exercises. So far in 2021, the count stands at no purchases and 1 sale.

The latest filing, published on 15 January 2021, reports an open-market sale of €389k in Axonics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.